home / stock / mdxg / mdxg news


MDXG News and Press, MiMedx Group Inc From 04/30/24

Stock Information

Company Name: MiMedx Group Inc
Stock Symbol: MDXG
Market: OTC
Website: mimedx.com

Menu

MDXG MDXG Quote MDXG Short MDXG News MDXG Articles MDXG Message Board
Get MDXG Alerts

News, Short Squeeze, Breakout and More Instantly...

MDXG - Expected US Company Earnings on Tuesday, April 30th, 2024

LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...

MDXG - Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers

2024-04-25 10:00:28 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance BofA watched clients retract $2B last week as the S&P dropped ...

MDXG - MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, April 3...

MDXG - MiMedx falls as FDA reaffirms position on Axiofill

2024-03-27 09:09:56 ET More on MiMedx Group MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript MiMedx Group: Restructuring Changes Are Paying Off MiMedx announces new senior secured credit facilities, debt refinancing MiMedx gets FDA warning letter ov...

MDXG - MIMEDX Provides Update on AXIOFILL® Request for Designation ("RFD") from FDA

Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the Market Reiterates Expectations for 2024 Net Sales Percentage Growth in the Low Doubl...

MDXG - TELA Bio launches Liquifix surgical devices in the U.S.

2024-03-21 07:59:20 ET More on TELA Bio TELA Bio: Looks Like A Buy, But Some Pieces Missing To Make This A Strong Buy Seeking Alpha’s Quant Rating on TELA Bio Historical earnings data for TELA Bio Financial information for TELA Bio Read the f...

MDXG - MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

MARIETTA, Ga., March 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has entered into an agreement with TELA Bio, Inc. to obtain exclusive rights to its manufacturing and supply agreement with Regenity ...

MDXG - (MDXG) Pivots Trading Plans and Risk Controls

2024-03-14 02:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MDXG - MIMEDX Introduces E-Commerce and Account Management Platform

MARIETTA, Ga., March 13, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the launch of MIMEDX Connect™, an online product ordering and account management portal available to its customers through the Company...

MDXG - MIMEDX Announces Appointment of Two New Independent Directors

MARIETTA, Ga., March 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointments of Tiffany Olson and Dorothy Puhy to its Board of Directors, effective as of March 1, 2024. Ms. Olson and Ms. Puhy each brin...

Previous 10 Next 10